PEBC Part I (MCQ) common mistakes
PEBC Part I (MCQ) · Understand the traps and how to avoid them.
When asked which drug causes a given adverse effect, selects the drug by matching the disease name to the usual first-line class, without tracing the drug's receptor or enzyme mechanism.
Part I rewards mechanism chains; candidates under time pressure rely on memorized top-10 lists and stop at 'beta-blocker' rather than 'beta-2 blockade in bronchial smooth muscle'.
What to do instead
For every drug class write a one-line mechanism-to-effect map (receptor → tissue → response → adverse effect) and practise explaining why a contraindication exists; if you cannot state the mechanism, mark it for review rather than guessing.
Uses first-order half-life equations for a drug that follows zero-order (saturable) kinetics, such as phenytoin or ethanol, or applies a loading-dose equation without checking volume of distribution and bioavailability.
Most pharmacokinetic practice uses first-order formulas; the stem may mention 'saturation' or 'nonlinear' only once, and candidates pattern-match to the familiar equation.
What to do instead
Before calculating, classify elimination order from the stem. For zero-order use amount/time (or Michaelis-Menten at high concentration); for first-order write the equation with units. Check whether half-life changes with dose. If it does, the drug is not first-order.
Picks the guideline first-line agent for the condition without scanning the stem for renal or hepatic impairment, pregnancy, age, interacting drugs, or allergy.
Stems are long; the diagnosis appears early and the disqualifying detail late, so candidates answer the textbook question rather than the patient's question.
What to do instead
Use a fixed four-box check before selecting therapy: indication, contraindication (organ function, pregnancy, allergy), interaction, and monitoring. If two options are both indicated, the differentiator is almost always one of those boxes.
Calculates a dose or concentration without carrying units through the setup, then reports an answer in mg when the question asked for mcg, or confuses % w/v with mg/mL.
Under time pressure candidates jump to arithmetic; percentage concentrations are taught as ratios but tested as labelled products.
What to do instead
Write a dimensional-analysis equation with units cancelling, convert to the requested unit before selecting, and sanity-check order of magnitude. For % w/v, convert explicitly: 1% = 1 g/100 mL = 10 mg/mL.
Chooses the option that reflects good clinical ethics, such as 'counsel the patient and document', when the question asks for the legal minimum or the specific jurisdictional requirement, such as a retention period, prescribing authority, or mandatory reporting.
Ethics and law overlap, and candidates default to the clinically safest option; the exam tests Canadian federal and provincial distinctions.
What to do instead
Tag each practice question as law or ethics before answering. For law, recall the specific statute or standard and the exact requirement; for ethics, apply the principle. Do not let a clinically attractive option override a legal 'must'.
Accepts a prescription as complete and proceeds to dispense without systematically checking prescriber authority, drug name, strength, formulation, dose, quantity, directions, and refills, and misses high-alert or look-alike/sound-alike names.
The dispensary workflow rewards speed; candidates read for the drug and skip the legality and completeness fields.
What to do instead
Use a written screening checklist (prescriber, patient, drug, dose, directions, quantity, refills, allergies, interactions) and apply it to every practice item. For high-alert drugs, require an independent double-check and clarify ambiguous handwriting rather than guessing.
Confuses formulary status, reimbursement eligibility, and therapeutic substitution rules, or answers adherence questions with a generic 'counsel the patient' rather than a behavioural model.
Administrative content is less clinically familiar and is often studied last; adherence models are memorized as names without matching interventions.
What to do instead
Build a one-page map of Canadian drug coverage pathways (federal, provincial, private) and the difference between formulary listing, restricted access, and substitution. For adherence, name the model and match the intervention to the patient's stage.
Selects the answer that avoids disagreement or is 'kindest', such as agreeing with the patient or not mentioning a prescribing error, instead of the response that meets informed consent, disclosure, and interprofessional escalation.
Candidates conflate empathy with agreement; the exam tests patient autonomy and safety, not conflict avoidance.
What to do instead
Ask: whose decision is it, what information does the patient need, and what must be documented or escalated? Choose the option that preserves the relationship while disclosing and documenting; use teach-back to confirm comprehension rather than assuming 'explain' is enough.
Interprets a screening test result using sensitivity and specificity alone, or labels an intervention as primary prevention when it is secondary or tertiary.
Sensitivity and specificity are threshold-independent and easy to memorize; positive predictive value depends on prevalence, which the stem may bury.
What to do instead
For every screening question draw a 2x2 table with the stated prevalence and calculate PPV and NPV. Classify prevention by the target population (pre-disease, early disease, complications) rather than by the intervention type.
Accepts a study's conclusion because the result is 'statistically significant', without checking design, comparator, allocation concealment, intention-to-treat, confidence intervals, or whether the outcome was patient-important.
Abstracts and stems foreground p-values; candidates have limited time to appraise methods.
What to do instead
Use a 60-second appraisal: design and comparator, randomization and blinding, intention-to-treat, effect size with confidence interval, and patient-important outcome. Convert relative risks or odds ratios to absolute risk reduction and number needed to treat when baseline risk is given; if the confidence interval crosses no effect, do not call it positive.